» Articles » PMID: 15767582

Suppression of Viral Infectivity Through Lethal Defection

Overview
Specialty Science
Date 2005 Mar 16
PMID 15767582
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

RNA viruses replicate with a very high error rate and give rise to heterogeneous, highly plastic populations able to adapt very rapidly to changing environments. Viral diseases are thus difficult to control because of the appearance of drug-resistant mutants, and it becomes essential to seek mechanisms able to force the extinction of the quasispecies before adaptation emerges. An alternative to the use of conventional drugs consists in increasing the replication error rate through the use of mutagens. Here, we report about persistent infections of lymphocytic choriomeningitis virus treated with fluorouracil, where a progressive debilitation of infectivity leading to eventual extinction occurs. The transition to extinction is accompanied by the production of large amounts of RNA, indicating that the replicative ability of the quasispecies is not strongly impaired by the mutagen. By means of experimental and theoretical approaches, we propose that a fraction of the RNA molecules synthesized can behave as a defective subpopulation able to drive the viable class extinct. Our results lead to the identification of two extinction pathways, one at high amounts of mutagen, where the quasispecies completely loses its ability to infect and replicate, and a second one, at lower amounts of mutagen, where replication continues while the infective class gets extinct because of the action of defectors. The results bear on a potential application of increased mutagenesis as an antiviral strategy in that low doses of a mutagenic agent may suffice to drive persistent virus to extinction.

Citing Articles

Fidelity Characterization of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus and NADC30-like Strain.

Gao X, Bian T, Gao P, Ge X, Zhang Y, Han J Viruses. 2024; 16(5).

PMID: 38793678 PMC: 11125636. DOI: 10.3390/v16050797.


Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus.

Martinez-Gonzalez B, Gallego I, Gregori J, Soria M, Somovilla P, de Avila A Antimicrob Agents Chemother. 2023; 67(7):e0039423.

PMID: 37367486 PMC: 10353389. DOI: 10.1128/aac.00394-23.


Favipiravir Suppresses Zika Virus (ZIKV) through Activity as a Mutagen.

Franco E, Cella E, Tao X, Hanrahan K, Azarian T, Brown A Microorganisms. 2023; 11(5).

PMID: 37317316 PMC: 10224157. DOI: 10.3390/microorganisms11051342.


Favipiravir Inhibits Zika Virus (ZIKV) Replication in HeLa Cells by Altering Viral Infectivity.

Franco E, Hanrahan K, Brown A Microorganisms. 2023; 11(5).

PMID: 37317071 PMC: 10223361. DOI: 10.3390/microorganisms11051097.


Quasispecies Nature of RNA Viruses: Lessons from the Past.

Singh K, Mehta D, Dumka S, Chauhan A, Kumar S Vaccines (Basel). 2023; 11(2).

PMID: 36851186 PMC: 9963406. DOI: 10.3390/vaccines11020308.


References
1.
Gerrish P, Garcia-Lerma J . Mutation rate and the efficacy of antimicrobial drug treatment. Lancet Infect Dis. 2002; 3(1):28-32. DOI: 10.1016/s1473-3099(03)00485-7. View

2.
Holland J, Domingo E, de la Torre J, Steinhauer D . Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol. 1990; 64(8):3960-2. PMC: 249691. DOI: 10.1128/JVI.64.8.3960-3962.1990. View

3.
Ruiz-Jarabo C, Ly C, Domingo E, de la Torre J . Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology. 2003; 308(1):37-47. DOI: 10.1016/s0042-6822(02)00046-6. View

4.
Eigen M . Error catastrophe and antiviral strategy. Proc Natl Acad Sci U S A. 2002; 99(21):13374-6. PMC: 129678. DOI: 10.1073/pnas.212514799. View

5.
Huynen M, Stadler P, Fontana W . Smoothness within ruggedness: the role of neutrality in adaptation. Proc Natl Acad Sci U S A. 1996; 93(1):397-401. PMC: 40245. DOI: 10.1073/pnas.93.1.397. View